"Somos una Empresa de Servicios Clínicos para la Industria Farmacéutica, única en la Argentina por la exclusiva especialización de sus servicios para la ejecución de Estudios Farmacocinéticos, Fase I, Biodisponibilidad y Bioequivalencia."

During the past decade, FP Clinical Pharma conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "FP Clinical Pharma" are "Bioequivalence" (1 trials), "Chagas Disease" (1 trials) and "Chagas' Disease" (1 trials). Many other conditions were trialed in "FP Clinical Pharma" in a lesser frequency.

Most popular intervention types in "FP Clinical Pharma" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Nifurtimox (Lampit, BAYA2502)" (2 trials), "Nifurtimox (Lampit, BAYA2502)_Reference" (1 trials) and "Nifurtimox (Lampit, BAYA2502)_Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "FP Clinical Pharma" are 3 trials for "All" genders.

Currently, there are NaN active trials in "FP Clinical Pharma". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in FP Clinical Pharma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in FP Clinical Pharma, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".